Clinical trial
Assessing the Predictive Value of the Global Limb Anatomic Staging System (GLASS) in EndoVascular Therapy (EVT) of Infrainguinal Lesions in Patients With Critical Limb-threatening Ischemia (CLTI): the GLASS-EVT Study
NCT05999669 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessing the Predictive Value of the Global Limb Anatomic Staging System (GLASS) in EndoVascular Therapy (EVT) of Infrainguinal Lesions in Patients With Critical Limb-threatening Ischemia (CLTI): the GLASS-EVT Study
- Lead sponsor
- RenJi Hospital
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- August 20, 2023
- Completion date
- December 31, 2027
- Enrollment
- 2,000 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.